Related Experiment Video
Updated: May 18, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen
1Department of Paediatrics, CF Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. christine.hansen@rh.regionh.dk
Purpose Of Review:
Stenotrophomonas maltophilia can cause persistent airway colonization and chronic infection in cystic fibrosis (CF) patients. The clinical effect of chronic S. maltophilia infection is still a matter of debate. The purpose of the review is to summarize studies published during the last 1.5 years with a focus on whether S. maltophilia should be regarded as a 'true' CF pathogen.
Recent Findings:
Studies concerning the microbiological characteristics of this microorganism with special focus on identification, virulence factors, cross-infection and resistance pattern, and studies on clinical effects of chronic infection, specifically serological responses to this infection, negative effects on the clinical status and possible effects of antibiotic treatment have been reviewed.
Summary:
S. maltophilia can be identified with certainty, has well-described virulence factors, is capable of cross-infection and often shows multiresistance. Although CF patients with chronic S. maltophilia infection have lower lung function parameters compared with other CF patients and experience more exacerbations, chronic S. maltophilia infection in itself was not associated with a worse clinical outcome. True, pathogenic effects of S. maltophilia could not be found, but the presence of chronic S. maltophilia could be a marker of more pronounced lung disease in affected patients.
Insights
Stenotrophomonas maltophilia is identified in cystic fibrosis (CF) patients, but its role as a pathogen is debated. While it doesn't worsen outcomes, its presence may indicate more severe lung disease in CF patients.
Area of Science:
- Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Stenotrophomonas maltophilia (S. maltophilia) is a bacterium frequently found in cystic fibrosis (CF) patients.
- Chronic S. maltophilia infection in CF is common, but its clinical significance remains controversial.
Purpose of the Study:
- To review recent literature (last 1.5 years) on S. maltophilia in CF.
- To determine if S. maltophilia should be classified as a 'true' pathogen in CF.
Main Methods:
- Literature review of studies published within the last 1.5 years.
- Analysis of microbiological characteristics, virulence factors, and resistance patterns.
- Evaluation of clinical effects, including serological responses and impact on lung function.
Main Results:
- S. maltophilia is identifiable, possesses virulence factors, facilitates cross-infection, and exhibits multidrug resistance.
- CF patients with chronic S. maltophilia infection show reduced lung function and increased exacerbations.
- No direct evidence of S. maltophilia causing a worse clinical outcome was found.
Conclusions:
- S. maltophilia is a well-characterized bacterium with concerning microbiological properties.
- Chronic S. maltophilia infection in CF patients is not directly linked to poorer clinical outcomes.
- The presence of S. maltophilia may serve as an indicator of more advanced lung disease in CF.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Colonisation of Pathogens
Bacterial Phylum Planctomycetes
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Bacterial Phylum Tenericutes
Bacterial Phylum Bacteroidota

